MR-Guided Laser Ablation of Prostate Bed Recurrences

Technical Success, Safety, and Short-term Efficacy for MR-Guided Laser Ablation of Prostate Bed Recurrences

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01743638

Enrollment

Registered

2012-12-06

Start date

2012-04-30

Completion date

2014-02-28

Last updated

2014-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Tumors

Brief summary

The purpose of this study is to see if MR-guided laser ablation can effectively treat prostate tumor recurrences.

Interventions

PROCEDUREMR-Guided Laser Ablation

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

50 Years to 95 Years

Healthy volunteers

Inclusion criteria

* Patients with biopsy proven soft tissue tumor recurrences of prostate fossa referred to Urology and/or Interventional Radiology for treatment. * Surgery is not a desirable alternative therapy at the time of enrollment * Radiation therapy has failed or not indicated or can be safely postponed * Tumor size ≤ 5 cm at its largest diameter * Tumor does not encompass the rectal wall or external urethral sphincter * Performance status is ECOG 2 or better in adults * Patient is able to undergo MRI

Exclusion criteria

* Patients with pacemaker or defibrillator

Design outcomes

Primary

Measure	Time frame
Measurement of target lesion(s) dimensions at 3-6 month imaging follow-up	3-6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026